CMS, CDC, and HHS Seek Public Input on Potential CLIA Updates
Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), and the Department of Health and Human Services...
The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.
The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.
Source:
https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2
Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), and the Department of Health and Human Services...
Most labs answer them as one, and that is what makes the decision expensive. Separating them is what makes it reversible. BY TELCOR WITH KWAMI...
The Centers for Medicare & Medicaid Services (CMS) posted the October 2026 Quarterly Update to the Clinical Laboratory Fee Schedule (CLFS) and...